Literature DB >> 8758905

Familial predisposition to neuroblastoma does not map to chromosome band 1p36.

J M Maris1, S M Kyemba, T R Rebbeck, P S White, E P Sulman, S J Jensen, C Allen, J A Biegel, R A Yanofsky, G L Feldman, G M Brodeur.   

Abstract

Familial predisposition to neuroblastoma, a common embryonal cancer of childhood, segregates as an autosomal dominant trait with high penetrance. It is therefore likely that neuroblastoma susceptibility is due to germ line mutations in a tumor suppressor gene. Cytogenetic, functional, and molecular studies have implicated chromosome band 1p36 as the most likely region to contain a suppressor gene involved in sporadic neuroblastoma tumorigenesis. We now demonstrate that neuroblastoma predisposition does not map to any of eight polymorphic markers spanning 1p36 by linkage analysis in three families. In addition, there is no loss of heterozygosity at any of these markers in tumors from affected members of these kindreds. Furthermore, there is strong evidence against linkage to two Hirschsprung disease (a condition that can cosegregate with neuroblastoma) susceptibility genes, RET and EDNRB. We conclude that the neuroblastoma susceptibility gene is distinct from the 1p36 tumor suppressor and the currently identified Hirschsprung disease susceptibility genes.

Entities:  

Mesh:

Year:  1996        PMID: 8758905

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

Review 1.  Diagnosis and classification of the small round-cell tumors of childhood.

Authors:  S L Cohn
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

2.  ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome.

Authors:  Franck Bourdeaut; Sandrine Ferrand; Laurence Brugières; Marjorie Hilbert; Agnès Ribeiro; Ludovic Lacroix; Jean Bénard; Valérie Combaret; Jean Michon; Dominique Valteau-Couanet; Bertrand Isidor; Xavier Rialland; Maryline Poirée; Anne-Sophie Defachelles; Michel Peuchmaur; Gudrun Schleiermacher; Gaëlle Pierron; Marion Gauthier-Villars; Isabelle Janoueix-Lerosey; Olivier Delattre
Journal:  Eur J Hum Genet       Date:  2011-11-09       Impact factor: 4.246

3.  Anticipation in pediatric malignancies.

Authors:  S E Plon
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

4.  Intracranial metastasis of neuroblastoma: in two different areas at the same time.

Authors:  Dogan Kose; Pinar Karabagli; Güler Yavas; Hakan Karabagli; Yavuz Koksal
Journal:  Childs Nerv Syst       Date:  2013-06-21       Impact factor: 1.475

5.  Relaxation effect of synthetic ceramide analogues in cat esophageal smooth muscle cells.

Authors:  Doo Won Lee; Sun Young Park; Jung Su Ryu; Sung Hyo Kim; Chae Uk Im; Su Hang Choi; Se Eun Lee; Sung Kwon Ko; Uy Dong Sohn
Journal:  Korean J Physiol Pharmacol       Date:  2008-08-31       Impact factor: 2.016

Review 6.  Neuroblastoma: evolving therapies for a disease with many faces.

Authors:  Robert E Goldsby; Katherine K Matthay
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

7.  Prenatal diagnosis of adrenal neuroblastoma: a case report with a brief review of the literature.

Authors:  Onur Erol; Dinç Süren; Melek Büyükkınacı Erol
Journal:  Case Rep Obstet Gynecol       Date:  2013-03-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.